ID   CP2CJ_HUMAN             Reviewed;         490 AA.
AC   P33261; P33259; Q8WZB1; Q8WZB2; Q9UCD4;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2005, sequence version 3.
DT   10-MAY-2017, entry version 167.
DE   RecName: Full=Cytochrome P450 2C19;
DE            EC=1.14.13.-;
DE   AltName: Full=(R)-limonene 6-monooxygenase;
DE            EC=1.14.13.80;
DE   AltName: Full=(S)-limonene 6-monooxygenase;
DE            EC=1.14.13.48;
DE   AltName: Full=(S)-limonene 7-monooxygenase;
DE            EC=1.14.13.49;
DE   AltName: Full=CYPIIC17;
DE   AltName: Full=CYPIIC19;
DE   AltName: Full=Cytochrome P450-11A;
DE   AltName: Full=Cytochrome P450-254C;
DE   AltName: Full=Mephenytoin 4-hydroxylase;
GN   Name=CYP2C19;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CYP2C19*1A).
RC   TISSUE=Liver;
RX   PubMed=2009263; DOI=10.1021/bi00227a012;
RA   Romkes M., Faletto M.B., Blaisdell J.A., Raucy J.L., Goldstein J.A.;
RT   "Cloning and expression of complementary DNAs for multiple members of
RT   the human cytochrome P450IIC subfamily.";
RL   Biochemistry 30:3247-3255(1991).
RN   [2]
RP   ERRATUM, AND SEQUENCE REVISION.
RX   PubMed=8095407; DOI=10.1021/bi00056a025;
RA   Romkes M., Faletto M.B., Blaisdell J.A., Raucy J.L., Goldstein J.A.;
RL   Biochemistry 32:1390-1390(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LEU-19; ASP-92;
RP   ALA-122; HIS-144; ILE-331 AND CYS-410.
RG   NIEHS SNPs program;
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-160 AND 274-490, AND VARIANT
RP   ILE-331.
RA   de Morais S.M.F., Blaisdell J.A.;
RT   "Gene structure, upstream region and allelic variants of cyp2c19, the
RT   s-mephenytoin hydroxylase.";
RL   Submitted (NOV-2001) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   PROTEIN SEQUENCE OF 1-16.
RC   TISSUE=Liver;
RX   PubMed=8215410; DOI=10.1006/abbi.1993.1506;
RA   Wrighton S.A., Stevens J.C., Becker G.W., VandenBranden M.;
RT   "Isolation and characterization of human liver cytochrome P450 2C19:
RT   correlation between 2C19 and S-mephenytoin 4'-hydroxylation.";
RL   Arch. Biochem. Biophys. 306:240-245(1993).
RN   [7]
RP   CHARACTERIZATION.
RX   PubMed=11950794; DOI=10.1124/dmd.30.5.602;
RA   Miyazawa M., Shindo M., Shimada T.;
RT   "Metabolism of (+)- and (-)-limonenes to respective carveols and
RT   perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes.";
RL   Drug Metab. Dispos. 30:602-607(2002).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.87 ANGSTROMS) OF 23-489 IN COMPLEX WITH HEME
RP   AND SYNTHETIC INHIBITOR, AND COFACTOR.
RX   PubMed=23118231; DOI=10.1074/jbc.M112.424895;
RA   Reynald R.L., Sansen S., Stout C.D., Johnson E.F.;
RT   "Structural characterization of human cytochrome P450 2C19: active
RT   site differences between P450s 2C8, 2C9, and 2C19.";
RL   J. Biol. Chem. 287:44581-44591(2012).
RN   [10]
RP   INVOLVEMENT IN POOR DRUG METABOLISM, AND IDENTIFICATION OF ALLELE
RP   CYP2C19*2A.
RX   PubMed=8195181;
RA   de Morais S.M.F., Wilkinson G.R., Blaisdell J., Nakamura K.,
RA   Meyer U.A., Goldstein J.A.;
RT   "The major genetic defect responsible for the polymorphism of S-
RT   mephenytoin metabolism in humans.";
RL   J. Biol. Chem. 269:15419-15422(1994).
RN   [11]
RP   INVOLVEMENT IN POOR DRUG METABOLISM, AND IDENTIFICATION OF ALLELE
RP   CYP2C19*3A.
RX   PubMed=7969038;
RA   De Morais S.M.F., Wilkinson G.R., Blaisdell J., Meyer U.A.,
RA   Nakamura K., Goldstein J.A.;
RT   "Identification of a new genetic defect responsible for the
RT   polymorphism of (S)-mephenytoin metabolism in Japanese.";
RL   Mol. Pharmacol. 46:594-598(1994).
RN   [12]
RP   VARIANT TRP-433.
RX   PubMed=9103550;
RA   Xiao Z.S., Goldstein J.A., Xie H.G., Blaisdell J., Wang W.,
RA   Jiang C.H., Yan F.X., He N., Huang S.L., Xu Z.H., Zhou H.H.;
RT   "Differences in the incidence of the CYP2C19 polymorphism affecting
RT   the S-mephenytoin phenotype in Chinese Han and Bai populations and
RT   identification of a new rare CYP2C19 mutant allele.";
RL   J. Pharmacol. Exp. Ther. 281:604-609(1997).
RN   [13]
RP   VARIANTS ASP-92 AND GLN-132.
RX   PubMed=9732415;
RA   Ibeanu G.C., Goldstein J.A., Meyer U.A., Benhamou S., Bouchardy C.,
RA   Dayer P., Ghanayem B.I., Blaisdell J.;
RT   "Identification of new human CYP2C19 alleles (CYP2C19*6 and
RT   CYP2C19*2B) in a Caucasian poor metabolizer of mephenytoin.";
RL   J. Pharmacol. Exp. Ther. 286:1490-1495(1998).
RN   [14]
RP   VARIANT TRP-433.
RX   PubMed=10022751;
RA   Ibeanu G.C., Blaisdell J., Ghanayem B.I., Beyeler C., Benhamou S.,
RA   Bouchardy C., Wilkinson G.R., Dayer P., Daly A.K., Goldstein J.A.;
RT   "An additional defective allele, CYP2C19*5, contributes to the S-
RT   mephenytoin poor metabolizer phenotype in Caucasians.";
RL   Pharmacogenetics 8:129-135(1998).
RN   [15]
RP   VARIANT ARG-120.
RX   PubMed=10411572;
RA   Ibeanu G.C., Blaisdell J., Ferguson R.J., Ghanayem B.I., Brosen K.,
RA   Benhamou S., Bouchardy C., Wilkinson G.R., Dayer P., Goldstein J.A.;
RT   "A novel transversion in the intron 5 donor splice junction of CYP2C19
RT   and a sequence polymorphism in exon 3 contribute to the poor
RT   metabolizer phenotype for the anticonvulsant drug S-mephenytoin.";
RL   J. Pharmacol. Exp. Ther. 290:635-640(1999).
RN   [16]
RP   VARIANTS PRO-17; LEU-19; HIS-144; HIS-150; LEU-227 AND CYS-410.
RX   PubMed=12464799; DOI=10.1097/00008571-200212000-00004;
RA   Blaisdell J., Mohrenweiser H., Jackson J., Ferguson S., Coulter S.,
RA   Chanas B., Xi T., Ghanayem B., Goldstein J.A.;
RT   "Identification and functional characterization of new potentially
RT   defective alleles of human CYP2C19.";
RL   Pharmacogenetics 12:703-711(2002).
RN   [17]
RP   VARIANT CYS-442.
RX   PubMed=15499191; DOI=10.2133/dmpk.19.236;
RA   Morita J., Kobayashi K., Wanibuchi A., Kimura M., Irie S.,
RA   Ishizaki T., Chiba K.;
RT   "A novel single nucleotide polymorphism (SNP) of the CYP2C19 gene in a
RT   Japanese subject with lowered capacity of mephobarbital 4'-
RT   hydroxylation.";
RL   Drug Metab. Pharmacokinet. 19:236-238(2004).
RN   [18]
RP   VARIANTS THR-74; HIS-144; LEU-168 AND ILE-331.
RX   PubMed=15469410; DOI=10.1517/14622416.5.7.895;
RA   Solus J.F., Arietta B.J., Harris J.R., Sexton D.P., Steward J.Q.,
RA   McMunn C., Ihrie P., Mehall J.M., Edwards T.L., Dawson E.P.;
RT   "Genetic variation in eleven phase I drug metabolism genes in an
RT   ethnically diverse population.";
RL   Pharmacogenomics 5:895-931(2004).
RN   [19]
RP   VARIANTS GLY-51; PRO-161; HIS-329 AND ILE-331.
RX   PubMed=16141610; DOI=10.2133/dmpk.20.300;
RA   Fukushima-Uesaka H., Saito Y., Maekawa K., Ozawa S., Hasegawa R.,
RA   Kajio H., Kuzuya N., Yasuda K., Kawamoto M., Kamatani N., Suzuki K.,
RA   Yanagawa T., Tohkin M., Sawada J.;
RT   "Genetic variations and haplotypes of CYP2C19 in a Japanese
RT   population.";
RL   Drug Metab. Pharmacokinet. 20:300-307(2005).
CC   -!- FUNCTION: Responsible for the metabolism of a number of
CC       therapeutic agents such as the anticonvulsant drug S-mephenytoin,
CC       omeprazole, proguanil, certain barbiturates, diazepam,
CC       propranolol, citalopram and imipramine.
CC   -!- CATALYTIC ACTIVITY: (+)-(R)-limonene + NADPH + O(2) = (+)-trans-
CC       carveol + NADP(+) + H(2)O.
CC   -!- CATALYTIC ACTIVITY: (-)-(S)-limonene + NADPH + O(2) = (-)-trans-
CC       carveol + NADP(+) + H(2)O.
CC   -!- CATALYTIC ACTIVITY: (-)-(S)-limonene + NADPH + O(2) = (-)-perillyl
CC       alcohol + NADP(+) + H(2)O.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC         Evidence={ECO:0000269|PubMed:23118231};
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral
CC       membrane protein. Microsome membrane; Peripheral membrane protein.
CC   -!- INDUCTION: P450 can be induced to high levels in liver and other
CC       tissues by various foreign compounds, including drugs, pesticides,
CC       and carcinogens.
CC   -!- POLYMORPHISM: Genetic variation in CYP2C19 is responsible for poor
CC       drug metabolism [MIM:609535]. Individuals can be characterized as
CC       either extensive metabolizers (EM) or poor metabolizers (PM). The
CC       PM phenotype is inherited in an autosomal recessive manner, with
CC       the EM phenotype comprising both homozygous dominant and
CC       heteroyzgote genotypes. There are marked interracial differences
CC       in the frequency of this polymorphism. Poor metabolizers represent
CC       2-5% of Caucasians, 13-23% of Asian populations, and as many as
CC       38-79% of individuals of some of the islands of Polynesia and
CC       Micronesia. Different alleles of CYP2C19 are known: CYP2C19*1A
CC       CYP2C19*1B, CYP2C19*1C, CYP2C19*2A (CYP2C19m1 or CYP2C19m1A),
CC       CYP2C19*2B (CYP2C19m1B), CYP2C19*2C (CYP2C19*21), CYP2C19*3A
CC       (CYP2C19m2), CYP2C19*3B (CYP2C19*20), CYP2C19*4 (CYP2C19m3),
CC       CYP2C19*5A (CYP2C19m4), CYP2C19*5B, CYP2C19*6, CYP2C19*7,
CC       CYP2C19*8, CYP2C19*9, CYP2C19*10, CYP2C19*11 CYP2C19*12,
CC       CYP2C19*13, CYP2C19*14 CYP2C19*15, CYP2C19*16, CYP2C19*18,
CC       CYP2C19*19. Defective CYP2C19*2 and CYP2C19*3 alleles are
CC       characterized by a splice mutation and a stop codon, respectively,
CC       and account for most of the PM alleles. The sequence shown is that
CC       of allele CYP2C19*1B.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   -!- CAUTION: P450-254C was originally listed as a separate gene
CC       (CYP2C17). Resequencing demonstrated that it is not a separate
CC       gene, but a chimera. The 5'-portion corresponds to a partial 2C18
CC       clone, and the 3'-portion corresponds to a partial 2C19 clone.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Cytochrome P450 Allele Nomenclature Committee;
CC       Note=CYP2C19 alleles;
CC       URL="http://www.cypalleles.ki.se/cyp2c19.htm";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/cyp2c19/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M61854; AAB59426.1; -; mRNA.
DR   EMBL; M61858; AAA52145.1; ALT_SEQ; mRNA.
DR   EMBL; L07093; AAA36660.1; ALT_SEQ; mRNA.
DR   EMBL; AY796203; AAV41877.1; -; Genomic_DNA.
DR   EMBL; AL583836; CAH74068.1; -; Genomic_DNA.
DR   EMBL; AL133513; CAH74068.1; JOINED; Genomic_DNA.
DR   EMBL; AL133513; CAH73444.1; -; Genomic_DNA.
DR   EMBL; AL583836; CAH73444.1; JOINED; Genomic_DNA.
DR   EMBL; L39098; AAL31347.1; -; Genomic_DNA.
DR   EMBL; L39097; AAL31347.1; JOINED; Genomic_DNA.
DR   EMBL; L39102; AAL31348.1; -; Genomic_DNA.
DR   EMBL; L39099; AAL31348.1; JOINED; Genomic_DNA.
DR   EMBL; L39100; AAL31348.1; JOINED; Genomic_DNA.
DR   EMBL; L39101; AAL31348.1; JOINED; Genomic_DNA.
DR   EMBL; L31506; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; L31507; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; L32982; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; L32983; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS7436.1; -.
DR   PIR; F38462; F38462.
DR   PIR; G38462; G38462.
DR   PIR; I52418; I52418.
DR   RefSeq; NP_000760.1; NM_000769.2.
DR   UniGene; Hs.282409; -.
DR   PDB; 4GQS; X-ray; 2.87 A; A/B/C/D=23-489.
DR   PDBsum; 4GQS; -.
DR   ProteinModelPortal; P33261; -.
DR   SMR; P33261; -.
DR   BioGrid; 107935; 2.
DR   STRING; 9606.ENSP00000360372; -.
DR   BindingDB; P33261; -.
DR   ChEMBL; CHEMBL3622; -.
DR   DrugBank; DB01418; Acenocoumarol.
DR   DrugBank; DB00945; Acetylsalicylic acid.
DR   DrugBank; DB00546; Adinazolam.
DR   DrugBank; DB00918; Almotriptan.
DR   DrugBank; DB06403; Ambrisentan.
DR   DrugBank; DB00357; Aminoglutethimide.
DR   DrugBank; DB01424; Aminophenazone.
DR   DrugBank; DB01118; Amiodarone.
DR   DrugBank; DB00321; Amitriptyline.
DR   DrugBank; DB01060; Amoxicillin.
DR   DrugBank; DB00701; Amprenavir.
DR   DrugBank; DB01435; Antipyrine.
DR   DrugBank; DB06605; Apixaban.
DR   DrugBank; DB00673; Aprepitant.
DR   DrugBank; DB01274; Arformoterol.
DR   DrugBank; DB06413; Armodafinil.
DR   DrugBank; DB06697; Artemether.
DR   DrugBank; DB00289; Atomoxetine.
DR   DrugBank; DB01076; Atorvastatin.
DR   DrugBank; DB06626; Axitinib.
DR   DrugBank; DB00972; Azelastine.
DR   DrugBank; DB00245; Benzatropine.
DR   DrugBank; DB01128; Bicalutamide.
DR   DrugBank; DB04794; Bifonazole.
DR   DrugBank; DB00188; Bortezomib.
DR   DrugBank; DB01558; Bromazepam.
DR   DrugBank; DB00835; Brompheniramine.
DR   DrugBank; DB00297; Bupivacaine.
DR   DrugBank; DB00921; Buprenorphine.
DR   DrugBank; DB00564; Carbamazepine.
DR   DrugBank; DB00748; Carbinoxamine.
DR   DrugBank; DB00395; Carisoprodol.
DR   DrugBank; DB00439; Cerivastatin.
DR   DrugBank; DB00446; Chloramphenicol.
DR   DrugBank; DB00672; Chlorpropamide.
DR   DrugBank; DB00169; Cholecalciferol.
DR   DrugBank; DB01166; Cilostazol.
DR   DrugBank; DB00501; Cimetidine.
DR   DrugBank; DB00604; Cisapride.
DR   DrugBank; DB00215; Citalopram.
DR   DrugBank; DB01211; Clarithromycin.
DR   DrugBank; DB04920; Clevidipine.
DR   DrugBank; DB00349; Clobazam.
DR   DrugBank; DB01242; Clomipramine.
DR   DrugBank; DB00758; Clopidogrel.
DR   DrugBank; DB01559; Clotiazepam.
DR   DrugBank; DB00257; Clotrimazole.
DR   DrugBank; DB00363; Clozapine.
DR   DrugBank; DB00531; Cyclophosphamide.
DR   DrugBank; DB00091; Cyclosporine.
DR   DrugBank; DB00250; Dapsone.
DR   DrugBank; DB00705; Delavirdine.
DR   DrugBank; DB01151; Desipramine.
DR   DrugBank; DB00967; Desloratadine.
DR   DrugBank; DB01234; Dexamethasone.
DR   DrugBank; DB01191; Dexfenfluramine.
DR   DrugBank; DB00514; Dextromethorphan.
DR   DrugBank; DB00829; Diazepam.
DR   DrugBank; DB00586; Diclofenac.
DR   DrugBank; DB00343; Diltiazem.
DR   DrugBank; DB01093; Dimethyl sulfoxide.
DR   DrugBank; DB01075; Diphenhydramine.
DR   DrugBank; DB00988; Dopamine.
DR   DrugBank; DB00590; Doxazosin.
DR   DrugBank; DB01142; Doxepin.
DR   DrugBank; DB00470; Dronabinol.
DR   DrugBank; DB00625; Efavirenz.
DR   DrugBank; DB00216; Eletriptan.
DR   DrugBank; DB00109; Enfuvirtide.
DR   DrugBank; DB08899; Enzalutamide.
DR   DrugBank; DB01175; Escitalopram.
DR   DrugBank; DB09119; Eslicarbazepine acetate.
DR   DrugBank; DB00736; Esomeprazole.
DR   DrugBank; DB00783; Estradiol.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00754; Ethotoin.
DR   DrugBank; DB01628; Etoricoxib.
DR   DrugBank; DB06414; Etravirine.
DR   DrugBank; DB00927; Famotidine.
DR   DrugBank; DB00949; Felbamate.
DR   DrugBank; DB00196; Fluconazole.
DR   DrugBank; DB01544; Flunitrazepam.
DR   DrugBank; DB00472; Fluoxetine.
DR   DrugBank; DB00499; Flutamide.
DR   DrugBank; DB01095; Fluvastatin.
DR   DrugBank; DB00176; Fluvoxamine.
DR   DrugBank; DB00983; Formoterol.
DR   DrugBank; DB01320; Fosphenytoin.
DR   DrugBank; DB00317; Gefitinib.
DR   DrugBank; DB01241; Gemfibrozil.
DR   DrugBank; DB01120; Gliclazide.
DR   DrugBank; DB01296; Glucosamine.
DR   DrugBank; DB01016; Glyburide.
DR   DrugBank; DB01018; Guanfacine.
DR   DrugBank; DB00502; Haloperidol.
DR   DrugBank; DB01355; Hexobarbital.
DR   DrugBank; DB06789; Hydroxyprogesterone caproate.
DR   DrugBank; DB01050; Ibuprofen.
DR   DrugBank; DB09054; Idelalisib.
DR   DrugBank; DB01181; Ifosfamide.
DR   DrugBank; DB00619; Imatinib.
DR   DrugBank; DB00458; Imipramine.
DR   DrugBank; DB00224; Indinavir.
DR   DrugBank; DB00328; Indomethacin.
DR   DrugBank; DB00951; Isoniazid.
DR   DrugBank; DB09570; Ixazomib.
DR   DrugBank; DB06738; Ketobemidone.
DR   DrugBank; DB01026; Ketoconazole.
DR   DrugBank; DB00448; Lansoprazole.
DR   DrugBank; DB01259; Lapatinib.
DR   DrugBank; DB08918; Levomilnacipran.
DR   DrugBank; DB01601; Lopinavir.
DR   DrugBank; DB00455; Loratadine.
DR   DrugBank; DB04871; Lorcaserin.
DR   DrugBank; DB00678; Losartan.
DR   DrugBank; DB00227; Lovastatin.
DR   DrugBank; DB08933; Luliconazole.
DR   DrugBank; DB09280; Lumacaftor.
DR   DrugBank; DB01283; Lumiracoxib.
DR   DrugBank; DB08932; Macitentan.
DR   DrugBank; DB01065; Melatonin.
DR   DrugBank; DB01043; Memantine.
DR   DrugBank; DB00532; Mephenytoin.
DR   DrugBank; DB00371; Meprobamate.
DR   DrugBank; DB00333; Methadone.
DR   DrugBank; DB00703; Methazolamide.
DR   DrugBank; DB00763; Methimazole.
DR   DrugBank; DB05246; Methsuximide.
DR   DrugBank; DB00849; Methylphenobarbital.
DR   DrugBank; DB00264; Metoprolol.
DR   DrugBank; DB01110; Miconazole.
DR   DrugBank; DB01171; Moclobemide.
DR   DrugBank; DB00745; Modafinil.
DR   DrugBank; DB09049; Naloxegol.
DR   DrugBank; DB00220; Nelfinavir.
DR   DrugBank; DB00622; Nicardipine.
DR   DrugBank; DB00184; Nicotine.
DR   DrugBank; DB00665; Nilutamide.
DR   DrugBank; DB06712; Nilvadipine.
DR   DrugBank; DB00717; Norethisterone.
DR   DrugBank; DB00540; Nortriptyline.
DR   DrugBank; DB00334; Olanzapine.
DR   DrugBank; DB00338; Omeprazole.
DR   DrugBank; DB04938; Ospemifene.
DR   DrugBank; DB00776; Oxcarbazepine.
DR   DrugBank; DB00239; Oxiconazole.
DR   DrugBank; DB06412; Oxymetholone.
DR   DrugBank; DB00213; Pantoprazole.
DR   DrugBank; DB00082; Pegvisomant.
DR   DrugBank; DB00738; Pentamidine.
DR   DrugBank; DB00312; Pentobarbital.
DR   DrugBank; DB00850; Perphenazine.
DR   DrugBank; DB00454; Pethidine.
DR   DrugBank; DB03783; Phenacetin.
DR   DrugBank; DB00780; Phenelzine.
DR   DrugBank; DB01174; Phenobarbital.
DR   DrugBank; DB00832; Phensuximide.
DR   DrugBank; DB00252; Phenytoin.
DR   DrugBank; DB01100; Pimozide.
DR   DrugBank; DB01132; Pioglitazone.
DR   DrugBank; DB01621; Pipotiazine.
DR   DrugBank; DB01179; Podofilox.
DR   DrugBank; DB06209; Prasugrel.
DR   DrugBank; DB01058; Praziquantel.
DR   DrugBank; DB00635; Prednisone.
DR   DrugBank; DB00794; Primidone.
DR   DrugBank; DB01032; Probenecid.
DR   DrugBank; DB00396; Progesterone.
DR   DrugBank; DB01131; Proguanil.
DR   DrugBank; DB00420; Promazine.
DR   DrugBank; DB00818; Propofol.
DR   DrugBank; DB00571; Propranolol.
DR   DrugBank; DB01589; Quazepam.
DR   DrugBank; DB01224; Quetiapine.
DR   DrugBank; DB00468; Quinine.
DR   DrugBank; DB01129; Rabeprazole.
DR   DrugBank; DB00980; Ramelteon.
DR   DrugBank; DB00863; Ranitidine.
DR   DrugBank; DB08896; Regorafenib.
DR   DrugBank; DB01045; Rifampicin.
DR   DrugBank; DB08864; Rilpivirine.
DR   DrugBank; DB00503; Ritonavir.
DR   DrugBank; DB06176; Romidepsin.
DR   DrugBank; DB00412; Rosiglitazone.
DR   DrugBank; DB01098; Rosuvastatin.
DR   DrugBank; DB01232; Saquinavir.
DR   DrugBank; DB01037; Selegiline.
DR   DrugBank; DB01104; Sertraline.
DR   DrugBank; DB00203; Sildenafil.
DR   DrugBank; DB00641; Simvastatin.
DR   DrugBank; DB06268; Sitaxentan.
DR   DrugBank; DB00398; Sorafenib.
DR   DrugBank; DB00259; Sulfanilamide.
DR   DrugBank; DB00675; Tamoxifen.
DR   DrugBank; DB06204; Tapentadol.
DR   DrugBank; DB00966; Telmisartan.
DR   DrugBank; DB00231; Temazepam.
DR   DrugBank; DB00444; Teniposide.
DR   DrugBank; DB00857; Terbinafine.
DR   DrugBank; DB00624; Testosterone.
DR   DrugBank; DB01041; Thalidomide.
DR   DrugBank; DB00679; Thioridazine.
DR   DrugBank; DB00208; Ticlopidine.
DR   DrugBank; DB00373; Timolol.
DR   DrugBank; DB01007; Tioconazole.
DR   DrugBank; DB00932; Tipranavir.
DR   DrugBank; DB08895; Tofacitinib.
DR   DrugBank; DB01124; Tolbutamide.
DR   DrugBank; DB01036; Tolterodine.
DR   DrugBank; DB00273; Topiramate.
DR   DrugBank; DB00214; Torasemide.
DR   DrugBank; DB05109; Trabectedin.
DR   DrugBank; DB00752; Tranylcypromine.
DR   DrugBank; DB00347; Trimethadione.
DR   DrugBank; DB00726; Trimipramine.
DR   DrugBank; DB00197; Troglitazone.
DR   DrugBank; DB01361; Troleandomycin.
DR   DrugBank; DB00580; Valdecoxib.
DR   DrugBank; DB00313; Valproic Acid.
DR   DrugBank; DB00285; Venlafaxine.
DR   DrugBank; DB00661; Verapamil.
DR   DrugBank; DB08828; Vismodegib.
DR   DrugBank; DB00582; Voriconazole.
DR   DrugBank; DB09068; Vortioxetine.
DR   DrugBank; DB00682; Warfarin.
DR   DrugBank; DB00549; Zafirlukast.
DR   DrugBank; DB00495; Zidovudine.
DR   DrugBank; DB00425; Zolpidem.
DR   DrugBank; DB00909; Zonisamide.
DR   GuidetoPHARMACOLOGY; 1328; -.
DR   SwissLipids; SLP:000001589; -.
DR   iPTMnet; P33261; -.
DR   PhosphoSitePlus; P33261; -.
DR   BioMuta; CYP2C19; -.
DR   DMDM; 60416369; -.
DR   PaxDb; P33261; -.
DR   PeptideAtlas; P33261; -.
DR   PRIDE; P33261; -.
DR   DNASU; 1557; -.
DR   Ensembl; ENST00000371321; ENSP00000360372; ENSG00000165841.
DR   GeneID; 1557; -.
DR   KEGG; hsa:1557; -.
DR   UCSC; uc010qnz.3; human.
DR   CTD; 1557; -.
DR   DisGeNET; 1557; -.
DR   GeneCards; CYP2C19; -.
DR   HGNC; HGNC:2621; CYP2C19.
DR   HPA; HPA015066; -.
DR   MalaCards; CYP2C19; -.
DR   MIM; 124020; gene.
DR   MIM; 609535; phenotype.
DR   neXtProt; NX_P33261; -.
DR   Orphanet; 413667; Antidepressant or antipsychotics toxicity or dose selection.
DR   Orphanet; 240935; Resistance to clopidogrel.
DR   Orphanet; 240921; Voriconazole toxicity.
DR   PharmGKB; PA124; -.
DR   eggNOG; KOG0156; Eukaryota.
DR   eggNOG; COG2124; LUCA.
DR   HOGENOM; HOG000036992; -.
DR   HOVERGEN; HBG015789; -.
DR   InParanoid; P33261; -.
DR   KO; K17721; -.
DR   OrthoDB; EOG091G0BT8; -.
DR   PhylomeDB; P33261; -.
DR   TreeFam; TF352043; -.
DR   BioCyc; MetaCyc:HS09293-MONOMER; -.
DR   Reactome; R-HSA-211981; Xenobiotics.
DR   Reactome; R-HSA-211999; CYP2E1 reactions.
DR   Reactome; R-HSA-2142670; Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET).
DR   Reactome; R-HSA-2142816; Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE).
DR   SABIO-RK; P33261; -.
DR   GeneWiki; CYP2C19; -.
DR   GenomeRNAi; 1557; -.
DR   PRO; PR:P33261; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000165841; -.
DR   CleanEx; HS_CYP2C19; -.
DR   ExpressionAtlas; P33261; baseline and differential.
DR   Genevisible; P33261; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; TAS:ProtInc.
DR   GO; GO:0031090; C:organelle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0052741; F:(R)-limonene 6-monooxygenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0018675; F:(S)-limonene 6-monooxygenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0018676; F:(S)-limonene 7-monooxygenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008392; F:arachidonic acid epoxygenase activity; IBA:GO_Central.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0020037; F:heme binding; IDA:UniProtKB.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0004497; F:monooxygenase activity; IDA:BHF-UCL.
DR   GO; GO:0016491; F:oxidoreductase activity; IDA:BHF-UCL.
DR   GO; GO:0019825; F:oxygen binding; TAS:Reactome.
DR   GO; GO:0008395; F:steroid hydroxylase activity; IMP:BHF-UCL.
DR   GO; GO:0017144; P:drug metabolic process; IDA:BHF-UCL.
DR   GO; GO:0019373; P:epoxygenase P450 pathway; IBA:GO_Central.
DR   GO; GO:0042738; P:exogenous drug catabolic process; IDA:BHF-UCL.
DR   GO; GO:0046483; P:heterocycle metabolic process; IDA:BHF-UCL.
DR   GO; GO:0016098; P:monoterpenoid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0097267; P:omega-hydroxylase P450 pathway; TAS:Reactome.
DR   GO; GO:0055114; P:oxidation-reduction process; IDA:BHF-UCL.
DR   GO; GO:0008202; P:steroid metabolic process; IMP:BHF-UCL.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:Reactome.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002401; Cyt_P450_E_grp-I.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00463; EP450I.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; SSF48264; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Endoplasmic reticulum; Heme; Iron; Membrane; Metal-binding; Microsome;
KW   Monooxygenase; NADP; Oxidoreductase; Polymorphism; Reference proteome.
FT   CHAIN         1    490       Cytochrome P450 2C19.
FT                                /FTId=PRO_0000051708.
FT   METAL       435    435       Iron (heme axial ligand).
FT   VARIANT      17     17       L -> P (in allele CYP2C19*14;
FT                                dbSNP:rs55752064).
FT                                {ECO:0000269|PubMed:12464799}.
FT                                /FTId=VAR_021268.
FT   VARIANT      19     19       I -> L (in allele CYP2C19*15;
FT                                dbSNP:rs17882687).
FT                                {ECO:0000269|PubMed:12464799,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_021269.
FT   VARIANT      51     51       S -> G (in allele CYP2C19*19).
FT                                {ECO:0000269|PubMed:16141610}.
FT                                /FTId=VAR_024083.
FT   VARIANT      74     74       M -> T (in dbSNP:rs28399505).
FT                                {ECO:0000269|PubMed:15469410}.
FT                                /FTId=VAR_024718.
FT   VARIANT      92     92       E -> D (in dbSNP:rs17878459).
FT                                {ECO:0000269|PubMed:9732415,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_021270.
FT   VARIANT     120    120       W -> R (in allele CYP2C19*8; loss of
FT                                activity; dbSNP:rs41291556).
FT                                {ECO:0000269|PubMed:10411572}.
FT                                /FTId=VAR_008357.
FT   VARIANT     122    122       E -> A (in dbSNP:rs17885179).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_021271.
FT   VARIANT     132    132       R -> Q (in allele CYP2C19*6; loss of
FT                                activity). {ECO:0000269|PubMed:9732415}.
FT                                /FTId=VAR_008358.
FT   VARIANT     144    144       R -> H (in allele CYP2C19*9;
FT                                dbSNP:rs17884712).
FT                                {ECO:0000269|PubMed:12464799,
FT                                ECO:0000269|PubMed:15469410,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_021272.
FT   VARIANT     150    150       R -> H (in allele CYP2C19*11;
FT                                dbSNP:rs58973490).
FT                                {ECO:0000269|PubMed:12464799}.
FT                                /FTId=VAR_021273.
FT   VARIANT     161    161       A -> P (in dbSNP:rs181297724).
FT                                {ECO:0000269|PubMed:16141610}.
FT                                /FTId=VAR_024084.
FT   VARIANT     168    168       F -> L (in dbSNP:rs28399510).
FT                                {ECO:0000269|PubMed:15469410}.
FT                                /FTId=VAR_024719.
FT   VARIANT     227    227       P -> L (in allele CYP2C19*10;
FT                                dbSNP:rs6413438).
FT                                {ECO:0000269|PubMed:12464799}.
FT                                /FTId=VAR_020123.
FT   VARIANT     329    329       R -> H (in allele CYP2C19*18).
FT                                {ECO:0000269|PubMed:16141610}.
FT                                /FTId=VAR_024085.
FT   VARIANT     331    331       V -> I (in allele CYP2C19*1A, allele
FT                                CYP2C19*5A, allele CYP2C19*8 and allele
FT                                CYP2C19*16; dbSNP:rs3758581).
FT                                {ECO:0000269|PubMed:15469410,
FT                                ECO:0000269|PubMed:16141610,
FT                                ECO:0000269|Ref.3, ECO:0000269|Ref.5}.
FT                                /FTId=VAR_001255.
FT   VARIANT     410    410       R -> C (in allele CYP2C19*13;
FT                                dbSNP:rs17879685).
FT                                {ECO:0000269|PubMed:12464799,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_021274.
FT   VARIANT     433    433       R -> W (in allele CYP2C19*5A and allele
FT                                CYP2C19*5B; loss of activity;
FT                                dbSNP:rs56337013).
FT                                {ECO:0000269|PubMed:10022751,
FT                                ECO:0000269|PubMed:9103550}.
FT                                /FTId=VAR_008359.
FT   VARIANT     442    442       R -> C (in allele CYP2C19*16; lowered
FT                                catalytic activity; dbSNP:rs192154563).
FT                                {ECO:0000269|PubMed:15499191}.
FT                                /FTId=VAR_021275.
FT   TURN         37     39       {ECO:0000244|PDB:4GQS}.
FT   HELIX        42     44       {ECO:0000244|PDB:4GQS}.
FT   HELIX        47     49       {ECO:0000244|PDB:4GQS}.
FT   HELIX        50     61       {ECO:0000244|PDB:4GQS}.
FT   STRAND       63     69       {ECO:0000244|PDB:4GQS}.
FT   STRAND       72     77       {ECO:0000244|PDB:4GQS}.
FT   HELIX        80     87       {ECO:0000244|PDB:4GQS}.
FT   TURN         88     90       {ECO:0000244|PDB:4GQS}.
FT   HELIX        91     94       {ECO:0000244|PDB:4GQS}.
FT   HELIX       103    106       {ECO:0000244|PDB:4GQS}.
FT   TURN        107    109       {ECO:0000244|PDB:4GQS}.
FT   HELIX       117    130       {ECO:0000244|PDB:4GQS}.
FT   STRAND      135    139       {ECO:0000244|PDB:4GQS}.
FT   HELIX       141    158       {ECO:0000244|PDB:4GQS}.
FT   TURN        159    161       {ECO:0000244|PDB:4GQS}.
FT   TURN        166    168       {ECO:0000244|PDB:4GQS}.
FT   HELIX       169    182       {ECO:0000244|PDB:4GQS}.
FT   STRAND      183    185       {ECO:0000244|PDB:4GQS}.
FT   HELIX       192    209       {ECO:0000244|PDB:4GQS}.
FT   HELIX       211    218       {ECO:0000244|PDB:4GQS}.
FT   HELIX       222    225       {ECO:0000244|PDB:4GQS}.
FT   HELIX       228    254       {ECO:0000244|PDB:4GQS}.
FT   HELIX       263    273       {ECO:0000244|PDB:4GQS}.
FT   TURN        274    276       {ECO:0000244|PDB:4GQS}.
FT   HELIX       284    297       {ECO:0000244|PDB:4GQS}.
FT   HELIX       300    315       {ECO:0000244|PDB:4GQS}.
FT   HELIX       317    330       {ECO:0000244|PDB:4GQS}.
FT   STRAND      333    335       {ECO:0000244|PDB:4GQS}.
FT   HELIX       339    344       {ECO:0000244|PDB:4GQS}.
FT   HELIX       346    359       {ECO:0000244|PDB:4GQS}.
FT   STRAND      377    379       {ECO:0000244|PDB:4GQS}.
FT   STRAND      386    389       {ECO:0000244|PDB:4GQS}.
FT   HELIX       391    395       {ECO:0000244|PDB:4GQS}.
FT   TURN        398    400       {ECO:0000244|PDB:4GQS}.
FT   STRAND      401    403       {ECO:0000244|PDB:4GQS}.
FT   HELIX       409    412       {ECO:0000244|PDB:4GQS}.
FT   STRAND      415    417       {ECO:0000244|PDB:4GQS}.
FT   HELIX       438    455       {ECO:0000244|PDB:4GQS}.
FT   STRAND      456    462       {ECO:0000244|PDB:4GQS}.
FT   TURN        464    466       {ECO:0000244|PDB:4GQS}.
FT   STRAND      475    477       {ECO:0000244|PDB:4GQS}.
FT   STRAND      485    489       {ECO:0000244|PDB:4GQS}.
SQ   SEQUENCE   490 AA;  55931 MW;  17DB04C50A132C53 CRC64;
     MDPFVVLVLC LSCLLLLSIW RQSSGRGKLP PGPTPLPVIG NILQIDIKDV SKSLTNLSKI
     YGPVFTLYFG LERMVVLHGY EVVKEALIDL GEEFSGRGHF PLAERANRGF GIVFSNGKRW
     KEIRRFSLMT LRNFGMGKRS IEDRVQEEAR CLVEELRKTK ASPCDPTFIL GCAPCNVICS
     IIFQKRFDYK DQQFLNLMEK LNENIRIVST PWIQICNNFP TIIDYFPGTH NKLLKNLAFM
     ESDILEKVKE HQESMDINNP RDFIDCFLIK MEKEKQNQQS EFTIENLVIT AADLLGAGTE
     TTSTTLRYAL LLLLKHPEVT AKVQEEIERV VGRNRSPCMQ DRGHMPYTDA VVHEVQRYID
     LIPTSLPHAV TCDVKFRNYL IPKGTTILTS LTSVLHDNKE FPNPEMFDPR HFLDEGGNFK
     KSNYFMPFSA GKRICVGEGL ARMELFLFLT FILQNFNLKS LIDPKDLDTT PVVNGFASVP
     PFYQLCFIPV
//
